Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam-alfentanil versus ciprofol sedation for colonoscopy
ChiCTR2300070996Phase 4Not yet recruiting
- Sponsor
- Liaoning Provincial People's Hospital
- Start
- May 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, alfentanil and ciprofol in None (2 arms), sponsored by Liaoning Provincial People's Hospital. Primary endpoint: Colonoscopy success rate. Planned start May 2023; status: not yet recruiting.
02
Drugs
remimazolamalfentanilciprofol
Beyond the preview
Go deeper on ChiCTR2300070996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070996.